ES2061406B1 - Nuevos derivados de la 2-(quinolina) con actividad farmacologica. - Google Patents

Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Info

Publication number
ES2061406B1
ES2061406B1 ES09300982A ES9300982A ES2061406B1 ES 2061406 B1 ES2061406 B1 ES 2061406B1 ES 09300982 A ES09300982 A ES 09300982A ES 9300982 A ES9300982 A ES 9300982A ES 2061406 B1 ES2061406 B1 ES 2061406B1
Authority
ES
Spain
Prior art keywords
quinoline
new derivatives
pharmacological activity
lipoxigenase
paf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09300982A
Other languages
English (en)
Other versions
ES2061406A1 (es
Inventor
Elena Carceller
Nuria Recasens
Carmen Almansa
Javier Bartroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to ES09300982A priority Critical patent/ES2061406B1/es
Priority to CA002123057A priority patent/CA2123057A1/en
Priority to EP94107134A priority patent/EP0624588A1/en
Priority to JP6119520A priority patent/JPH072868A/ja
Publication of ES2061406A1 publication Critical patent/ES2061406A1/es
Application granted granted Critical
Publication of ES2061406B1 publication Critical patent/ES2061406B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

NUEVOS DERIVADOS DE LA 2-(QUINOLINA) CON ACTIVIDAD FARMACOLOGICA. NUEVOS DERIVADOS DE LA 2-(QUINOLINA) DE FORMULA I, EN DONDE N ES 0 O 1, Y SUS SALES Y SOLVATOS. LA PRESENTE INVENCION DESCRIBE TAMBIEN PROCEDIMIENTOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS COMPUESTOS SON ANTAGONISTAS DUALES DEL PAF Y LA 5-LIPOXIGENASA, Y POR LO TANTO, SON UTILES EN EL TRATAMIENTO Y/O PREVENCION DE LAS ENFERMEDADES DONDE EL PAF Y/O LA 5-LIPOXIGENASA SE HALLAN IMPLICADOS.
ES09300982A 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica. Expired - Fee Related ES2061406B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09300982A ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
CA002123057A CA2123057A1 (en) 1993-05-07 1994-05-06 Quinoline derivatives with pharmacological activity
EP94107134A EP0624588A1 (en) 1993-05-07 1994-05-06 New quinoline derivatives with pharmacological activity
JP6119520A JPH072868A (ja) 1993-05-07 1994-05-09 薬理活性を有する新規なキノリン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300982A ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Publications (2)

Publication Number Publication Date
ES2061406A1 ES2061406A1 (es) 1994-12-01
ES2061406B1 true ES2061406B1 (es) 1995-06-01

Family

ID=8281737

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300982A Expired - Fee Related ES2061406B1 (es) 1993-05-07 1993-05-07 Nuevos derivados de la 2-(quinolina) con actividad farmacologica.

Country Status (4)

Country Link
EP (1) EP0624588A1 (es)
JP (1) JPH072868A (es)
CA (1) CA2123057A1 (es)
ES (1) ES2061406B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433167B1 (en) 1997-06-25 2002-08-13 Nikken Chemicals Co., Ltd. Triazolo-1,4-diazepine compounds and medicinal composition containing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
FI95708C (fi) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
JP2971901B2 (ja) * 1990-03-15 1999-11-08 エーザイ株式会社 トリアゾロ―１，４―ジアゼピン系化合物
US5179105A (en) * 1990-10-16 1993-01-12 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds, method for production thereof, and pharmaceutical preparations containing same
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4107521A1 (de) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg Neue acylaminosubstituierte hetrazepine
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents

Also Published As

Publication number Publication date
CA2123057A1 (en) 1994-11-08
JPH072868A (ja) 1995-01-06
EP0624588A1 (en) 1994-11-17
ES2061406A1 (es) 1994-12-01

Similar Documents

Publication Publication Date Title
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
PA8480101A1 (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos
CR20120007A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
PA8452201A1 (es) Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos.
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
BR9912866A (pt) Composto ou uma forma tautomérica, sal ousolvato farmaceuticamente aceitável do mesmo,composição farmacêutica, processo para otratamento ou a prevenção de uma doença, fatorde risco ou condição, mediada por hppar alfa e/ouhppar gama, e uso de um composto
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
PA8431301A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion
ES2161290T3 (es) Derivados de quinazolina.
SV2002000047A (es) Procedimientos e intermedios para preparar compuestos anticancerosos ref.pc10188 abcz
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
PA8524401A1 (es) DERIVADOS DE 4-Fenil-piridin
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AR002690A1 (es) Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado.
DK599789D0 (da) 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2067874T3 (es) Derivados de acetamida.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.
MX9204342A (es) Indoles.
ES2109276T3 (es) Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304